Adare's Srinivasan Shanmugam addresses the complexities of oral GLP-1 analog formulation and shares effective strategies to overcome these challenges.
.png?width=363&height=236&name=Right%20the%20First%20Time%20in%202026%20Modern%20Strategies%20to%20De-Risk%20Complex%20Oral%20Programs%20Under%20Capital%20Pressure%20(1).png)
